Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,735.00
Bid: 3,775.00
Ask: 3,790.00
Change: -50.00 (-1.32%)
Spread: 15.00 (0.397%)
Open: 3,820.00
High: 3,820.00
Low: 3,735.00
Prev. Close: 3,785.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jun 2023 07:00

RNS Number : 7720C
RHI Magnesita N.V.
15 June 2023
 

RHI Magnesita N.V.

("RHI Magnesita" the "Company" or the "Group")

TRADING UPDATE

 

RHI Magnesita, the leading global supplier of high‐grade refractory products, systems and solutions, today provides an update on trading for the five months ended 31 May 2023 (the "Period").

 

Trading update for the five months ended 31 May 2023

The momentum of improving profitability and margins delivered in Q1 2023 continued in April and May, as refractory pricing was largely maintained against a background of reducing costs.

Refractory sales volumes in the Period excluding M&A were 7% lower year on year, in line with overall market demand. Steel, cement and glass demand outside of India remains soft due to a slowdown in construction activity, with some glass project postponements now evident. Demand in the non-ferrous metals segment continues to be resilient. As anticipated due to the subdued demand backdrop and reducing input costs, the Group is beginning to experience sales price deflation in a number of its markets which is expected to continue and possibly accelerate through the remainder of the year.

Refractory EBITA margin contribution for the Period, which excludes vertical integration benefits, was better than expected, supported by cost deflation in April and May, as the cost of freight and purchased raw material reduced, partially offset by weaker fixed cost absorption due to lower production volumes.

The continued lower pricing environment for magnesite-based raw materials means that the Group's vertical integration EBITA margin contribution remains subdued and in line with the 1.8% of Group margin delivered in the second half of 2022.

As a result, the overall Adjusted EBITA margin for the Period was 12.1% (2022: 11.6%), delivering Unaudited Adjusted EBITA of €174 million (2022: €155 million).

 

Financial position

Net debt to EBITDA remains at a similar level to the 2.1x reported at 31 March 2023, including a 12 month historic contribution from businesses acquired during the period.

Absolute net debt at 31 May 2023 was largely unchanged from 31 December 2022, supported by strong operating cashflow. The Group continues to retain significant liquidity of €1.2 billion.

Net Working capital (before consolidation of M&A) was down slightly from its 31 December 2022 level, as reductions in inventory and accounts receivable were largely offset by lower accounts payable. The Group continues to prioritise security of supply for its customers in order to support recent market share gains.

Total capital expenditure in the five months to 31 May 2023 was €42 million, out of overall guidance of €200 million for 2023, with spending weighted towards the second half.

M&A increased net debt by €268 million in the first five months of the year, which was partially offset by the Qualified Institutional Placement ("QIP") by RHI Magnesita India Ltd, which raised approximately €101 million in April 2023. The QIP is to be followed by an equity investment of €22 million by the Group in RHI Magnesita India Ltd via a Preferential Issue which is expected to complete in June 2023. In the second half of the year the previously announced acquisition of Seven Refractories for a cash consideration of €95 million is expected to be completed.

 

Outlook

The outlook for the Group's key end markets and consequently customer volumes remains uncertain, with the order book currently suggesting only a moderate volume increase in H2, if at all, resulting in ongoing under-absorption of fixed costs. Pricing pressure is expected to continue and possibly accelerate through the remainder of the year.

Supported by the stronger than expected performance in the first five months of the year, the Board now expects a modest outperformance on its earlier 2023 EBITA and EBITA margin guidance.

Leverage, measured as a ratio of net debt to EBITDA, is expected to remain above 2.0x as the Group further executes on its M&A pipeline.

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel +43 699 1870 6490

E‐mail: chris.bucknall@rhimagnesita.com

 

For media enquiries:

Hudson Sandler

Tel +44 020 7796 4133

E-mail: rhimagnesita@hudsonsandler.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 13,500 employees in 33 main production sites and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefitting from more dynamic economic growth prospects.

The Group maintains a premium listing on the Official list of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the prime segment of the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (596/2014/EU).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKQBNDBKBCAD
Date   Source Headline
21st Nov 20227:00 amRNSAcquisition of Dalmia Bharat Refractories Limited
8th Nov 20222:00 pmRNSDirector/PDMR Shareholding
7th Nov 20223:49 pmRNSDirector/PDMR Shareholding
19th Oct 20227:00 amRNSEarnings on track for full year expectations
17th Oct 20224:29 pmRNSDirectorate Change
1st Aug 20227:00 amRNSRHI Magnesita half-year results
22nd Jul 20222:00 pmRNSNotice of 2022 Interim Results
1st Jun 20229:52 amRNSDirector Declaration
25th May 20223:59 pmRNSResult of AGM
12th May 20227:00 amRNSQ1 2022 Trading Update
13th Apr 20227:15 amRNSNotice of AGM
28th Mar 20227:00 amRNSRecycling joint venture
9th Mar 202210:01 amRNS2022 Long Term Incentive Plan Awards
4th Mar 20229:10 amRNSDirector/PDMR Shareholding
4th Mar 20229:06 amRNSDirector/PDMR Shareholding
28th Feb 20227:00 amRNS2021 Full Year Results
31st Jan 20224:20 pmRNSNotice of 2021 Full Year Results
6th Jan 20228:58 amRNSDirector Declaration
15th Dec 20213:13 pmRNSAppointment of an Employee Representative Director
14th Dec 20214:55 pmRNSChange of Employee Representative Directors
2nd Dec 20217:00 amRNSDebt Financing Update
25th Oct 20212:20 pmRNSDirector/PDMR Shareholding
19th Oct 20211:37 pmRNSDirector/PDMR Shareholding
19th Oct 20217:00 amRNSQ3 2021 Trading update and acquisition of SÖRMAS
5th Aug 20217:00 amRNSCompletion of share buyback
4th Aug 20215:22 pmRNSTransaction in Own Shares
3rd Aug 20216:25 pmRNSTransaction in Own Shares
2nd Aug 20216:00 pmRNSTransaction in Own Shares
30th Jul 20215:43 pmRNSTransaction in Own Shares
29th Jul 20215:49 pmRNSTransaction in Own Shares
28th Jul 20215:13 pmRNSTransaction in Own Shares
28th Jul 20217:00 amRNSHalf-year Report
27th Jul 20216:31 pmRNSTransaction in Own Shares
26th Jul 20215:21 pmRNSTransaction in Own Shares
23rd Jul 20215:58 pmRNSTransaction in Own Shares
22nd Jul 20215:19 pmRNSTransaction in Own Shares
21st Jul 20215:37 pmRNSTransaction in Own Shares
21st Jul 20215:17 pmRNSNotice of Results
20th Jul 20215:32 pmRNSTransaction in Own Shares
19th Jul 20216:11 pmRNSTransaction in Own Shares
16th Jul 20216:01 pmRNSTransaction in Own Shares
15th Jul 20215:48 pmRNSTransaction in Own Shares
14th Jul 20215:22 pmRNSTransaction in Own Shares
14th Jul 202111:23 amRNSHolding(s) in Company
13th Jul 20216:21 pmRNSTransaction in Own Shares
12th Jul 20214:59 pmRNSTransaction in Own Shares
9th Jul 20215:39 pmRNSTransaction in Own Shares
8th Jul 20216:03 pmRNSTransaction in Own Shares
7th Jul 20215:33 pmRNSTransaction in Own Shares
6th Jul 20215:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.